Table 5. Baseline CD4% and concentrations of the biomarkers in patients who were known to have died or known to be still alive after the first 5 years of follow-up.
| CD4% | β2 m(mg/L) | Neopterin(nmol/L) | sUPAR(µg/L) | |||||||||||||
| HIV-1 | HIV-2 | HIV-1 | HIV-2 | HIV-1 | HIV-2 | HIV-1 | HIV-2 | |||||||||
| Alive (n = 49) | Dead (n = 14) | Alive(n = 91) | Dead (n = 16) | Alive (n = 49) | Dead (n = 14) | Alive (n = 91) | Dead(n = 16) | Alive (n = 49) | Dead(n = 14) | Alive (n = 91) | Dead(n = 16) | Alive (n = 49) | Dead(n = 14) | Alive (n = 91) | Dead(n = 16) | |
| median | 34 | 36 | 34 | 33.5 | 2.28 | 3.20 | 1.65 | 2.64 | 12.3 | 19.7 | 9.8 | 19.0 | 4.16 | 4.08 | 3.90 | 5.35 |
| minimum | 28 | 29 | 28 | 29 | 0.96 | 1.16 | 0.75 | 1.55 | 4.0 | 6.8 | 3.6 | 6.5 | 1.00 | 2.60 | 2.00 | 3.00 |
| 25th percentile | 29 | 33 | 31 | 30.5 | 1.78 | 1.74 | 1.32 | 2.15 | 7.9 | 9.2 | 6.9 | 10.8 | 3.30 | 3.40 | 3.00 | 4.68 |
| 75th percentile | 39 | 41 | 38 | 36 | 2.91 | 5.11 | 2.49 | 3.49 | 20.3 | 50.2 | 17.6 | 28.8 | 5.01 | 5.62 | 5.50 | 7.25 |
| maximum | 60 | 49 | 61 | 42 | 5.35 | 9.36 | 5.80 | 15.47 | 108.0 | 101.6 | 151.3 | 141.4 | 17.00 | 43.40 | 19.40 | 8.70 |
| p-value* | 0.456 | 0.346 | 0.021 | 0.023 | 0.024 | 0.047 | 0.191 | 0.126 | ||||||||
*
Effect of baseline CD4% or biomarker concentration on odds of death within 5 years using logistic regression.